Skip to main content

Table 3 Effect of PJ intake on the incidence rate, rate ratio and attributable risk of first and second CVD events

From: Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?

CV Events Group Incidence rate Rate ratio P.V (95% CI) Attribute risk
First event PJ 10 648.24 PM × 1000 = 15.42 1000 PM 0.61 0.30 (0.25-1.5) 25.03 1000 PM - 15.42 1000 PM 25.03 1000 PM × 100 = 38.4 %
Placebo 9 359.57 PM × 1000 = 25.03 1000 PM   
Second event PJ 2 701.42 PM × 1000 = 2.85 1000 PM 0.54 0.55 (0.08-3.9) 5.34 1000 PM - 2.85 1000 PM 5.34 1000 PM × 100 = 46.3 %
Placebo 2 376.46 PM × 1000 = 5.31 1000 PM